Pacific Ridge Capital Partners’s Amedisys AMED Stock Holding History

Pacific Ridge Capital Partners’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-16,840	Closed	-$814K	–	151
2016 Q1	$814K	Buy	16,840 +60	+0.4%	+$2.31K	0.36%	85
2015 Q4	$660K	Hold	16,780	–	–	0.3%	100
2015 Q3	$637K	Sell	16,780 -2,510	-13%	-$106K	0.31%	102
2015 Q2	$766K	Sell	19,290 -2,267	-11%	-$70.6K	0.32%	104
2015 Q1	$577K	Buy	21,557 +430	+2%	+$12.1K	0.23%	117
2014 Q4	$620K	Buy	21,127 +230	+1%	+$5.68K	0.26%	117
2014 Q3	$421K	Buy	20,897 +7,297	+54%	+$141K	0.22%	134
2014 Q2	$228K	Sell	13,600 -70	-0.5%	-$992	0.16%	144
2014 Q1	$204K	Hold	13,670	–	–	0.14%	149
2013 Q4	$200K	Buy	+13,670	New	+$220K	0.14%	144

Other funds holding AMED

KKRC

Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

RIM

RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Pacific Ridge Capital Partners's AMED Position: Q2 2016 in Review

Pacific Ridge Capital Partners sold out of Amedisys (AMED) in Q2 2016, closing a stake of 16,840 shares — an estimated $814K sold.

Pacific Ridge Capital Partners first reported a position in AMED in Q4 2013 and held it in 10 quarters. The position peaked at $814K in Q1 2016. 168 funds tracked by Wall St. Rank hold AMED as of Q2 2016.

Pacific Ridge Capital Partners reported no remaining Amedisys position as of Q2 2016 after selling out during the quarter.
Pacific Ridge Capital Partners sold 16,840 Amedisys shares in Q2 2016, an estimated $814K.
Pacific Ridge Capital Partners first reported a position in Amedisys in Q4 2013 and held it in 10 quarters.
Pacific Ridge Capital Partners's Amedisys position peaked at $814K in Q1 2016.
168 funds tracked by Wall St. Rank held Amedisys as of Q2 2016.

Based on Pacific Ridge Capital Partners's 13F filing for Q2 2016, filed 10 Aug 2016.